• Astellas buys Potenza Therapeutics for up to $405m pharmaceutical-technology
    December 18, 2018
    Japanese pharmaceutical company Astellas Pharma has acquired US-based Potenza Therapeutics for a total consideration of up to $405m.
  • Astellas Acquires Potenza Therapeutics pharmafocusasia
    December 17, 2018
    Astellas Pharma Inc today announced that it exercised, and closed on its exclusive option to acquire Potenza Therapeutics, Inc. ("Potenza") on December 13, 2018, U.S. Eastern Time.....
PharmaSources Customer Service